BioFocus lands €7.5m drug discovery deal

BioFocus is to help deliver drug development candidates for Spanish pharmaceutical, Almirall, as part of a three-year collaboration worth up to €7.5 million (£6.25m).

The research will focus on a key respiratory target of interest to Almirall, who will provide its respiratory expertise while BioFocus, part of Galapagos NV, applies its integrated drug discovery capabilities.

 

 

blog comments powered by Disqus